CYCC Bio Green Med Solution Inc.


$ 1.40 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 12:19:32 EST
QQQ $ 609.96 $ -7.71 (-1.25 %)
DIA $ 477.91 $ -3.45 (-0.72 %)
SPY $ 674.69 $ -5.79 (-0.85 %)
TLT $ 89.87 $ 0.07 (0.08 %)
GLD $ 386.29 $ -1.01 (-0.26 %)
$ 1.44
$ 1.40
$ 1.37 x 100
$ 1.42 x 4
$ 1.40 - $ 1.46
$ 1.33 - $ 101.30
64,588
na
na
$ 1.30
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION